Adherence to riluzole in patients with amyotrophic lateral sclerosis: an observational study

OBJECTIVE: Riluzole is the first drug approved to treat amyotrophic lateral sclerosis (ALS). Recently, an oral suspension (OS) of riluzole was made available. Thus, the aim of our study was to evaluate the adherence to 2 formulations of riluzole in patients with ALS. PATIENTS AND METHODS: We enrolle...

Descripción completa

Detalles Bibliográficos
Autores principales: Introna, Alessandro, D’Errico, Eustachio, Modugno, Boris, Scarafino, Antonio, Fraddosio, Angela, Distaso, Eugenio, Tempesta, Irene, Mastronardi, Antonella, Simone, Isabella Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757977/
https://www.ncbi.nlm.nih.gov/pubmed/29379292
http://dx.doi.org/10.2147/NDT.S150550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757977/
https://www.ncbi.nlm.nih.gov/pubmed/29379292
http://dx.doi.org/10.2147/NDT.S150550

Ejemplares similares